Quest Diagnostics Declares Quarterly Cash Dividend
SECAUCUS, N.J., Nov. 10, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.86 per share, payable on January 27, 2027, to shareholders of record of Quest Diagnostics common stock on January 12, 2027.
About Quest Diagnostics
Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, we help reveal new avenues to identify and treat disease, empower healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three American adults each year, and our nearly 60,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-302935557.html
This press release may not be republished, redistributed, resold or sublicensed without the prior written approval of PR Newswire.
AlphAI analysis
Written by AlphAI from the release above, not by the issuer or PR Newswire. Informational, not investment advice.
The 30-second read
Why it matters
The dividend adds a modest cash return, likely supporting short‑term price stability.
Market read
A routine corporate action that may attract dividend‑seeking investors but has limited impact on broader market sentiment.
What to watch
Potential tax considerations for dividend‑receiving shareholders and the company's ability to sustain payouts.
Background
Quest Diagnostics is a leading provider of diagnostic information services with a large U.S. customer base.
Ticker impact
Quest Diagnostics announced a quarterly cash dividend of $0.86 per share, the first public disclosure of this payout.
likely slight upward pressure as the market prices in the new dividend yield
Dividends are generally viewed positively; the amount is modest but adds cash return, which can support the stock briefly.
Market effects
Adds a modest dividend to the healthcare diagnostics sector, but unlikely to shift sector dynamics.
Limited to US investors; no broader regional effect.
Low; the news is company‑specific and does not affect global markets.
Counterpoint
The dividend is small relative to the company's cash flow and may not justify a price increase.
Key entities
- companyQuest Diagnostics
Provider of diagnostic information services, ticker DGX.